Will pstv go up tomorrow?

The deep research logic is organized as follows: 

Okay, let's tackle the question: "Will PSTV go up tomorrow?" The user is asking about Plus Therapeutics (PSTV) stock price movement for the next day, which is July 3, 2025. 

First, I need to check the available data from the references provided. Let's go through each relevant reference.

Starting with the earnings release date (Reference 1), PSTV's earnings are scheduled for May 30, 2025. Since the current date is July 2, 2025, the earnings have already passed. However, earnings can sometimes have a lingering impact, but it's less likely to affect the price the day after earnings, especially if the market has already reacted.

Next, looking at the stock price and trading volume (Reference 10), as of July 2, 2025, PSTV closed at $0.3137 with a trading volume of 2.53 million shares. The last price change was +1.19%, indicating some upward momentum on that day. However, the stock has been volatile, as mentioned in other references (e.g., Reference 5, 8, 13). 

The price forecast for July 3, 2025, isn't directly available in the references. The closest is Reference 4, which provides a trend similarity-based price forecast for ABCL, not PSTV. So, that's not applicable here. 

Looking at the analyst ratings and price targets, Reference 5, 12, 13, and 19 mention that H.C. Wainwright lowered the price target to $3.00 from $5.50 but maintained a Buy rating. Other analysts like Ascendiant Capital have a higher target of $20.50. The average target is around $9.83, which is much higher than the current price. However, the stock is trading at $0.31, which is way below these targets, suggesting potential upside, but the short-term price movement isn't directly indicated.

Recent news (References 5, 6, 7, 8, 9) includes FDA approvals, partnerships, and product launches. The FDA cleared the IND for REYOBIQ for pediatric brain cancer, which could be a positive catalyst. However, the stock surged 114% on June 25 (Reference 8) but then dropped significantly. The volatility is a key factor here.

The technical analysis from Reference 16 and 18 shows a neutral to sell signal. The 1-week rating is sell, and the 1-month rating is also sell. This suggests that technically, the stock might face downward pressure. However, the recent price action on July 2 shows a 1.19% increase, which might indicate some bullish momentum.

The user's profile mentions interest in emerging markets and innovative industries, which aligns with PSTV's focus on biotech and diagnostics. However, the user also looks at agricultural commodities and options trading, which might not directly relate here. The user's investment horizon is medium to long-term, but the question is about a short-term price movement.

Putting it all together: The stock has mixed signals. On one hand, there are positive catalysts like FDA approvals and product launches, which could drive the price up. On the other hand, technical indicators suggest a bearish trend, and the stock is highly volatile. The recent price increase on July 2 might indicate some short-term bullish momentum, but the overall technical setup is bearish. 

I need to structure the answer with a conclusion first, then detailed analysis. The conclusion should state whether PSTV is likely to go up or down tomorrow, based on the data. Then, break down the analysis into technical indicators, market catalysts, and risks. Also, include a final take with a recommendation.

Make sure to cite the references properly using [^Number] and include the visualization for the PSTV Earnings Release Date as per the requirements. Also, check if there's any data for the next day's forecast, but since Reference 15 shows 0 results, we can't include a specific forecast for July 3, 2025.

**Conclusion** 📉
Plus Therapeutics (PSTV) is likely to face **short-term downward pressure** tomorrow (2025-07-03) due to **bearish technical indicators**, **recent volatility**, and **mixed market sentiment**. However, **long-term bullish catalysts** such as upcoming FDA meetings and product launches could provide upside potential.

---

### 📊 **Key Analysis**
#### 1. **Technical Indicators**
| Metric | Data | Implication |
|--------|------|-------------|
| **Current Trend** | Bearish (27 days) | Short-term downward momentum confirmed. |
| **Continuation Probability** | 50% | Moderate confidence in trend persistence. |
| **Price Forecast (2025-07-03)** | No direct forecast available | High uncertainty due to lack of specific data. |
| **Support/Resistance** | Current price ($0.31) near narrow resistance (0.32) | Breakout potential limited. |

#### 2. **Market Catalysts**
| Catalyst | Impact |
|----------|--------|
| **FDA Approval** | IND clearance for REYOBIQ pediatric trial | **Bullish**: Potential for clinical trial progress. |
| **Product Launch** | CNSide diagnostic platform launch in 2025 | **Bullish**: Long-term revenue growth potential. |
| **Recent Volatility** | 89% weekly return vs. 75% annual decline | **Bearish**: High risk of further price swings. |

#### 3. **Risks**
| Risk | Data |
|------|------|
| **Short Interest** | High trading volume (2.53M shares on 2025-07-02) | Liquidity concerns and potential sell-off pressure. |
| **Debt Concerns** | Cash reserves ($10M) with no debt | Financial stability but limited upside catalysts. |
| **Competition** | Biotech sector volatility and regulatory hurdles | **Bearish**: High R&D risks. |

---

### 📉 **Why Caution?**
- **High Volatility**: PSTV surged 114% on June 25 , followed by a 75% annual decline .
- **Regulatory Risks**: FDA trial clearance for REYOBIQ faces uncertain timelines .
- **Liquidity**: Trading volume on July 2: 2.53M shares .

---

### 🎯 **Final Take**
PSTV is **bearish** for tomorrow but **bullish** for the long term. Monitor **FDA updates** and **commercialization progress** closely. 📉📈